Ligand validation:1PP9

CDL: CARDIOLIPIN

CDL is a Ligand Of Interest in 1PP9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1PP9_CDL_Q_3003	14%	43%	0.21	0.846	1.08	1.14	4	4	0	0	50%	0.5
1PP9_CDL_G_2004	12%	40%	0.254	0.88	1.12	1.2	2	4	5	0	44%	0.44
1PP9_CDL_T_3004	11%	42%	0.258	0.871	1.14	1.1	4	2	0	0	49%	0.49
1PP9_CDL_G_2003	4%	44%	0.273	0.739	1.09	1.07	2	4	0	0	50%	0.5
2A06_CDL_C_2004	20%	39%	0.208	0.913	1.14	1.23	3	4	0	0	44%	0.44
6ZFT_CDL_C_408	19%	65%	0.241	0.938	0.49	0.84	-	2	0	0	44%	0.44
5OKD_CDL_C_408	19%	30%	0.227	0.921	1.5	1.3	4	5	0	0	44%	0.44
1PPJ_CDL_T_3004	18%	41%	0.23	0.911	1.13	1.15	4	3	2	0	49%	0.49
5NMI_CDL_P_406	16%	33%	0.223	0.886	1.14	1.49	3	7	2	0	46%	0.46
5Y5S_CDL_M_415	41%	34%	0.128	0.953	1.32	1.27	3	3	1	0	39%	0.39
2GNU_CDL_M_1309	38%	22%	0.122	0.984	1.77	1.5	3	3	0	0	10%	10
3ZDQ_CDL_A_1721	37%	64%	0.215	0.943	0.72	0.65	4	4	0	1	84%	0.42
6JY3_CDL_B_301	33%	24%	0.163	0.908	1.53	1.57	5	14	0	0	64%	0.64
7COH_CDL_A_521	33%	72%	0.212	0.901	0.46	0.6	-	2	6	0	94%	0.94

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.